Share Twitter LinkedIn Facebook Email Sara M. Tolaney, MD, MPH, talks about whether CDK4/6 inhibitors can be used interchangeably at Annual Meeting 2018.
ASCO 2025 Guidelines on Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer: A Game-Changer in Oncology ASCO 5 Mins Read
2025 Breast Cancer Updates: Dr. Evanthia Roussos Torres on Biomarkers, Immunotherapy, and the Future of Treatment – MOASC Breast 6 Mins Read